Ativo Capital Management LLC Edwards Lifesciences Corp Transaction History

Ativo Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $50,980 - $64,170	-500 Reduced 3.6%	13,379 $1.58 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $26,592 - $32,670	250 Added 1.83%	13,879 $1.8 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $27,991 - $33,388	272 Added 2.04%	13,629 $1.54 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $251 - $314	-3 Reduced 0.02%	13,357 $1.38 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $9,048 - $10,427	115 Added 0.87%	13,360 $1.12 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $269,633 - $350,896	-4,013 Reduced 23.25%	13,245 $1.06 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $993,025 - $1.33 Million	17,258 New	17,258 $1.19 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ativo Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ativo Capital Management LLC with notifications on news.